# Preemptive IV Ibuprofen for Neurocognitive Recovery and Analgesic Needs After Inguinal Hernia Surgery

> **NCT07424001** · PHASE4 · COMPLETED · sponsor: **Mehmet Çiğdem** · enrollment: 76 (actual)

## Conditions studied

- Inguinal Hernia Unilateral
- Delayed Neurocognitive Recovery
- Postoperative Pain
- Neuroinflammation
- Preemptive Analgesia

## Interventions

- **DRUG:** Ibuprofen (400 mg x 4)
- **OTHER:** Placebo (NaCl 0.9 % solution)

## Key facts

- **NCT ID:** NCT07424001
- **Lead sponsor:** Mehmet Çiğdem
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-27
- **Primary completion:** 2026-01-22
- **Final completion:** 2026-01-30
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2026-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07424001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07424001, "Preemptive IV Ibuprofen for Neurocognitive Recovery and Analgesic Needs After Inguinal Hernia Surgery". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07424001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*